EGFR and neoplasm: Interestingly, in vivo studies confirmed a decrease in tumor weight of xenograft models as compared to control, through the reduced expression of oncogenic proteins EGFR, Akt and cyclin D1, and enhanced caspase 3/8 activities, while being harmless to other tissues in xenograft models [94,95].